Literature DB >> 7545081

Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody.

A Samuelson1, M Forsgren, M Sällberg.   

Abstract

The epitope for a monoclonal antibody reactive against different enteroviruses was characterized. The epitope could be located to residues 40 to 48 of VP1, and the most-essential residues for monoclonal antibody binding coincided with those conserved among the majority of known enteroviruses, indicating a high diagnostic potential.

Mesh：

Substances：

Year:  1995        PMID： 7545081      PMCID： PMC170165          DOI： 10.1128/cdli.2.3.385-386.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  9 in total

1.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins.

Authors:  M Sällberg; U Rudén; L O Magnius; E Norrby; B Wahren
Journal:  Immunol Lett       Date:  1991-09       Impact factor: 3.685

3.  Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody.

Authors:  G E Yousef; I N Brown; J F Mowbray
Journal:  Intervirology       Date:  1987       Impact factor: 1.763

4.  The complete nucleotide sequence of enterovirus type 70: relationships with other members of the picornaviridae.

Authors:  M D Ryan; O Jenkins; P J Hughes; A Brown; N J Knowles; D Booth; P D Minor; J W Almond
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

5.  Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses.

Authors:  T Pöyry; T Hyypiä; C Horsnell; L Kinnunen; T Hovi; G Stanway
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

6.  A distinct picornavirus group identified by sequence analysis.

Authors:  T Hyypiä; C Horsnell; M Maaronen; M Khan; N Kalkkinen; P Auvinen; L Kinnunen; G Stanway
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

7.  Epidemiological features of type 22 echovirus infection.

Authors:  A Ehrnst; M Eriksson
Journal:  Scand J Infect Dis       Date:  1993

8.  Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.

Authors:  Z X Zhang; M Chen; K Wallhagen; J Trojnar; L O Magnius; B Wahren; M Sällberg
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

9.  Molecular basis for serological cross-reactivity between enteroviruses.

Authors:  A Samuelson; M Forsgren; B Johansson; B Wahren; M Sällberg
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
  9 in total
  13 in total

1.  Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.

Authors:  Erin S Haley; Gough G Au; Brian R Carlton; Richard D Barry; Darren R Shafren
Journal:  J Mol Med (Berl)       Date:  2009-01-13       Impact factor: 4.599

Review 2.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Rapid shell vial culture technique for detection of enteroviruses and adenoviruses in fecal specimens: comparison with conventional virus isolation method.

Authors:  G J Van Doornum; J C De Jong
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.

Authors:  Nicole Ettischer-Schmid; Andrea Normann; Martina Sauter; Lisa Kraft; Hubert Kalbacher; Reinhard Kandolf; Bertram Flehmig; Karin Klingel
Journal:  Virchows Arch       Date:  2016-08-27       Impact factor: 4.064

5.  Monoclonal antibodies to VP1 recognize a broad range of enteroviruses.

Authors:  Lynn Yihong Miao; Christina Pierce; Jennifer Gray-Johnson; Jill DeLotell; Carl Shaw; Nate Chapman; Elaine Yeh; David Schnurr; Yung T Huang
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

6.  Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.

Authors:  Sarah J Richardson; Pia Leete; Shalinee Dhayal; Mark A Russell; Maarit Oikarinen; Jutta E Laiho; Emma Svedin; Katharina Lind; Therese Rosenling; Nora Chapman; Adrian J Bone; Alan K Foulis; Gun Frisk; Malin Flodstrom-Tullberg; Didier Hober; Heikki Hyoty; Noel G Morgan
Journal:  Diabetologia       Date:  2013-11-05       Impact factor: 10.122

7.  Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes.

Authors:  Hongyi Zhang; Yanwen Li; Dougal R McClean; Peter J Richardson; Richard Florio; Mary Sheppard; Karen Morrison; Najma Latif; Michael J Dunn; Leonard C Archard
Journal:  Med Microbiol Immunol       Date:  2003-11-22       Impact factor: 3.402

8.  Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring.

Authors:  Hanna Viskari; Mikael Knip; Sisko Tauriainen; Heini Huhtala; Riitta Veijola; Jorma Ilonen; Olli Simell; Heljä-Marja Surcel; Heikki Hyöty
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

9.  Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.

Authors:  Shoichiro Tanaka; Yoriko Nishida; Kaoru Aida; Taro Maruyama; Akira Shimada; Masako Suzuki; Hiroki Shimura; Soichi Takizawa; Masashi Takahashi; Daiichiro Akiyama; Sayaka Arai-Yamashita; Fumihiko Furuya; Akio Kawaguchi; Masahiro Kaneshige; Ryohei Katoh; Toyoshi Endo; Tetsuro Kobayashi
Journal:  Diabetes       Date:  2009-07-29       Impact factor: 9.461

10.  Properties of Two Enterovirus Antibodies that are Utilized in Diabetes Research.

Authors:  Giuseppe Maccari; Angelo Genoni; Silvia Sansonno; Antonio Toniolo
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.